Showing 421 - 440 results of 926 for search 'Hansard~', query time: 2.15s Refine Results
  1. 421
  2. 422

    Olabiyi Babalola J. Yai (1939-2020): Philosopher, Polymath, Humanist by Sanya Osha

    Published 2022-01-01
    “…He passed within three months of returning to Harvard in the United States where he had been based and then it fell upon his dear friend, Professor Olabiyi Babalola Yai to inform me. …”
    Get full text
    Article
  3. 423
  4. 424
  5. 425
  6. 426

    Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study by Nirmish Shah, Menaka Bhor, Lin Xie, Steve Arcona, Rashid Halloway, Jincy Paulose, Huseyin Yuce

    Published 2019-05-01
    “…Patients with VOCs were associated with a higher risk for death (hazard ratio=1.56; 95% confidence interval: [1.19-2.05]) or acute complications including acute chest syndrome, stroke, pulmonary embolism, splenic sequestration, and pulmonary hypertension. …”
    Get full text
    Article
  7. 427

    Role of the CHADS-VASc score in predicting hospital stay and 90-day readmission among patients with atrial fibrillation in Syria by Ibrahim Antoun, Alamer Alkhayer, Alkassem Alkhayer, Yaman Mahfoud, Ahmed Kotb, Riyaz Somani, G André Ng, Mustafa Zakkar

    Published 2025-02-01
    “…There was an incremental increase in the hazard ratio (HR) of readmission from a score of 1 (HR: 2.3, 95% CI: 1.3–4.1) to a score of >6 (HR: 41, 95% CI: 31–72) compared with a CHA 2 DS 2 -VASc of 0. …”
    Get full text
    Article
  8. 428

    The Maddaloni/X-6 eruption stands out as one of the major events during the Late Pleistocene at Campi Flegrei by Giada Fernandez, Antonio Costa, Biagio Giaccio, Jacopo Natale, Danilo M. Palladino, Gianluca Sottili

    Published 2025-01-01
    “…This study provides insights into the capability of the Campi Flegrei magmatic system to repeatedly generate large explosive eruptions, which has broad implications for hazard assessment in the central Mediterranean area.…”
    Get full text
    Article
  9. 429

    Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations by Jason C.S. Ho, K.M. Cheung

    Published 2024-01-01
    “…The addition of durvalumab did not improve real-world recurrence-free survival (rwRFS) in patients with these mutations (hazard ratio [HR] 0.852, 95 % confidence interval [CI] 0.394 – 1.843, p= 0.683). …”
    Get full text
    Article
  10. 430

    Risk of hepatocellular carcinoma in Asian patients with primary biliary cholangitis: A nationwide and hospital cohort study by Jihye Lim, Ye-Jee Kim, Sehee Kim, Jonggi Choi

    Published 2025-02-01
    “…Older age (subdistribution hazard ratio [SHR]: 1.05, 95% CI: 1.00–1.10), male sex (SHR: 3.00, 95% CI: 1.11–8.13), current alcohol consumption (SHR: 3.70, 95% CI: 1.08–12.59), and cirrhosis (SHR: 5.17, 95% CI: 2.07–12.93) were identified as risk factors in the hospital cohort. …”
    Get full text
    Article
  11. 431
  12. 432

    Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort by Hye-Jin Yoo, Jae-Young Kim, Jeong-Ju Yoo, Hye Won Lee, Sang Gyune Kim, Young Seok Kim

    Published 2025-02-01
    “…Cox regression analysis showed that the TAF group had a significantly lower HCC incidence compared with the TDF (hazard ratio 1.335, p <0.001) and ETV groups (hazard ratio 1.162, p = 0.011), after adjusting for age, gender, and cirrhosis status. …”
    Get full text
    Article
  13. 433

    Efficacy and safety of laquinimod versus placebo in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials by Malik Waleed Zeb Khan, Aizaz Ali, Amna Hussain, Safeena Khan, Ammara Tahir, Muhammad Haris Khan, Touba Azeem, Abdul Moeez, Arysha Monis, Aban Masaud Mian, Fazia Khattak, Moosa Ali, Jibran Ikram

    Published 2025-02-01
    “…For disability progression confirmed at 3 months, laquinimod provided a significant advantage over placebo (hazard ratio [HR] = 0.75, 95% CI = 0.59, 0.96, I 2  = 25%), whereas no benefit was achieved at 6 months (HR = 0.69, 95% CI = 0.45, 1.06, I 2  = 66%). …”
    Get full text
    Article
  14. 434

    Meta-Analysis and Systematic Review of the Role of Appendectomy in the Pathogenesis of Colorectal Cancer by M.I. A. Nezhad, N. P. Yabandeh

    Published 2024-05-01
    “…We assessed the impact of appendectomy on colorectal cancer, employing a random effects model to calculate the pooled hazard ratio (HR) for developing CRC post-appendectomy and its 95 % confidence interval (CI).Results. …”
    Get full text
    Article
  15. 435
  16. 436
  17. 437
  18. 438
  19. 439
  20. 440

    Evolution of artificial intelligence in healthcare: a 30-year bibliometric study by Yaojue Xie, Yuansheng Zhai, Yuansheng Zhai, Guihua Lu, Guihua Lu

    Published 2025-01-01
    “…The United States and China emerged as primary contributors to medical artificial intelligence research, with Harvard University leading in publication volume among institutions. …”
    Get full text
    Article